DiaSorin

The LIAISON® XL is designed with you in mind. By automating routine tasks and minimizing human error, it frees up your team to focus on what matters most: patient care. With a wider range of premium specialty tests, you can confidently address the growing challenges of infectious diseases, gastrointestinal health, and women's health. Our goal is to empower you to do more with less. Less manual work, less chance of errors, and less stress. More efficient workflows, more accurate results, and more satisfied patients. Are you ready to experience the LIAISON® XL difference? Visit today our page dedicated and contact us to learn more: https://lnkd.in/d9et5sfZ #LIAISONXL #laboratoryefficiency #patientcare #healthcareimprovement #clinicaldiagnostics

Check out our blog to read the highlights of the interview about Diasorin’s solutions for customizable molecular respiratory testing and, the ways labs can streamline their workflows to meet their diagnostic stewardship goals.  At the Association for Diagnostics & Laboratory Medicine, Diasorin team members Michelle Tabb, Chief Scientific Officer, and Giulia Amicarelli, Vice President of Global Molecular Marketing and Marketing Services, offered great insight into the shifting landscape, current challenges, and the latest innovations in respiratory testing in their interview with the Medical Laboratory Observer  Read the blog: https://hubs.li/Q02Tw5px0 #Diasorin #LIAISONPLEX

Do you know if the coverage might have changed for COVID-19 testing now that the pandemic is over, and COVID-19 is no longer a public health emergency?  If you’re looking for a breakdown of what may or may not be covered, as well as various reimbursement policies under Medicare, Medicaid, private insurance, and the safety nets for those uninsured, check out our blog for a quick summary:  https://hubs.li/Q02Tw0ZX0 #HealthcareReimbursement #Diasorin

The post-pandemic world has brought with it many lessons in diagnostic stewardship, one of which is that a one-size-fits-all approach is not always optimal. Watch Stephanie Ibbotson, Sr. Director of Strategic Marketing and Market Access discusses how laboratories benefit from staying prepared through a shifting respiratory landscape. Ready to hear more? Click here: https://hubs.li/Q02TwkWF0 #LIASIONPLEX #LIAISONMDX #diagnosticstewardship

Pneumonia remains a major infectious disease with high morbidity, mortality, and healthcare costs worldwide. However, in approximately 50% of community-acquired pneumonia (CAP) cases, the causative pathogens cannot be identified due to limitations in traditional microbiological methods, making timely and accurate diagnosis a challenge. We will share our experience with a new automated solution that addresses the limitations of current tests. With the peak season approaching, laboratories are being challenged by the increasing number of tests. Discover how Urinary Antigen Tests (UATs) for 𝑆𝑡𝑟𝑒𝑝𝑡𝑜𝑐𝑜𝑐𝑐𝑢𝑠 𝑝𝑛𝑒𝑢𝑚𝑜𝑛𝑖𝑎𝑒 and 𝐿𝑒𝑔𝑖𝑜𝑛𝑒𝑙𝑙𝑎 𝑝𝑛𝑒𝑢𝑚𝑜𝑝ℎ𝑖𝑙𝑎 can improve workflow, speed diagnosis and enhance patient management. 📅 November 7, 2024 Save the date and register for the webinar 🔗 https://lnkd.in/dC9w_JSq

Are you looking to optimize your respiratory testing menu in the wake of the COVID-19 pandemic? Stephanie Ibbotson, Sr. Director of Strategic Marketing and Market Access discusses the various challenges and strategies in post-pandemic respiratory testing in our new video, "Diagnostics Stewardship: A path for better patient treatment and health economics." Want to watch the full video? Click here: https://hubs.li/Q02TwkVP0 #Diasorin #RespiratoryTesting #diagnosticstewardship

You won’t want to miss our presentation in Learning Lounge 5 on Friday morning, October 18th! Hear Gregory Berry, PhD., D(ABMM), and Jacky Chow, PhD., D(ABMM), discuss Diasorin’s new molecular testing solutions for identifying fungal pathogens: The first FDA De Novo granted molecular assay for identifying C. auris colonization and a new sample-to-answer molecular panel to detect and identify yeasts from positive blood culture bottles. Plus, be sure to stop by Booth #448 to learn more about optimizing respiratory testing through Flex Testing with our LIAISON PLEX® Respiratory Flex Assay, run on our LIAISON PLEX® System.   In the meantime, learn more about our products here: https://hubs.li/Q02SY4j00. #IDWeek #IDWeek2024

Stop by the Poster Hall on Thursday, October 17th at 12:15 p.m. and speak with Kaisha Gonzalez, PhD., Regional Director, Scientific Affairs at Diasorin about her poster, “Epidemiology of Respiratory Pathogens and the Impact of Seasonality, Patient Demographics, and Diagnostic Testing Approach: A Retrospective Analysis from 2022 to 2023.” You will find her at Poster #702.  We invite you to come see the poster and visit us at Booth #448, where we’ll be featuring our new molecular testing solutions for both fungal and respiratory pathogens. Plus, learn more about our extensive portfolio of immunodiagnostic specialty assays, designed for critical and high-impact testing on our LIAISON® family of analyzers. We hope to see you there!  In the meantime, learn more about our products here: https://hubs.li/Q02SXVnH0. #IDWeek #IDWeek2024

Diasorin is hosting a presentation at IDWeek 2024 on Friday, October 18th at 10:15 a.m. in Learning Lounge 5. Hear Gregory Berry, PhD., D(ABMM), and Jacky Chow, PhD., D(ABMM), discuss Diasorin’s new molecular testing solutions for identifying fungal pathogens: The first FDA De Novo granted molecular assay for identifying C. auris colonization and a new sample-to-answer molecular panel to detect and identify yeasts from positive blood culture bottles. Be sure to stop by Booth #448 to learn more about our new molecular testing solutions for both fungal and respiratory pathogens, as well as our extensive portfolio of immunodiagnostic specialty assays, designed for critical and high-impact testing on our LIAISON® family of analyzers. See our full portfolio of products here: https://hubs.li/Q02SX_JT0. #IDWeek #IDWeek2024

Are you at ASM Clinical Virology Symposium October 7–9 in Long Beach, CA, today? Find us at Booth #316, where you can meet our experts and discover our latest FDA-cleared products. Don’t miss your chance to discover the state-of-the-art LIAISON PLEX® System and the fully customizable LIAISON PLEX® Respiratory Flex Assay. Learn about Simplexa® Direct Kits featuring a unique menu of targeted molecular assays, including HSV 1 & 2, VZV, and congenital CMV—all approved for various sample types. We look forward to connecting with you! #ASMCVS #ClinicalVirology #LabInnovation Want to learn more about our products, visit our website: https://hubs.li/Q02SnVlD0